penicillanic acid has been researched along with Liver Dysfunction in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (75.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
He, ZF; Wang, YP; Wu, XA | 1 |
DRAGO, U; FINOTTO, E; ONGARO, G | 1 |
Aratani, H; Miyamoto, S; Negita, S; Tateishi, H | 1 |
Barba, D; Esposito, S; Galante, D; Ruffilli, MP | 1 |
4 other study(ies) available for penicillanic acid and Liver Dysfunction
Article | Year |
---|---|
Severe bone marrow suppression and hepatic dysfunction caused by piperacillin/tazobactam.
Topics: Adult; Agranulocytosis; Bone Marrow; Humans; Liver; Liver Diseases; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Thrombocytopenia | 2013 |
[CLINICAL OBSERVATIONS ON THE THERAPEUTIC ACTIVITY OF 6(D(--)ALPHA-AMINOPHENYLACETAMIDO)-PENICILLANIC ACID (AMPICILLIN)].
Topics: Ampicillin; Cholangitis; Cholecystitis; Humans; Liver Diseases; Penicillanic Acid; Penicillins; Respiratory Tract Diseases; Urinary Tract Infections | 1964 |
[Fundamental studies on excretion of pivmecillinam in bile (author's transl)].
Topics: Amdinocillin Pivoxil; Animals; Bile; Liver Diseases; Male; Penicillanic Acid; Rabbits | 1981 |
Clinical efficacy and safety of sulbactam/ampicillin in patients suffering from chronic liver disease.
Topics: Adult; Aged; Aged, 80 and over; Ampicillin; Bacterial Infections; beta-Lactamase Inhibitors; Chronic Disease; Drug Combinations; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Liver Diseases; Liver Function Tests; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Sulbactam | 1987 |